Neuland Laboratoriesの将来のP / E
Neuland Laboratoriesの将来のP / Eは何ですか。
Neuland Laboratories Limitedの将来のP / Eは19.34です。
将来のP / Eの定義は何ですか。
未来比率P / E (株価収益率)は、企業の株価と今後12ヶ月間の1株当たり利益見込額との比率です。
The forward price to earnings ratio is similar to trailing price to earnings ratio but instead of net income uses estimated net earnings over next 12 months. Estimates are typically derived as the mean of those published by a select group of analysts with selection criteria varying. The forward price-to-earnings ratio is a powerful, but limited tool. It allows a quick snapshot of the company’s finances without getting down in the details of an accounting report.
BSEのセクタHealth Careにおける将来のP / Eの企業と比べるNeuland Laboratories
Neuland Laboratoriesは何をしますか。
Neuland Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. The company's APIs are used in various therapeutic areas, including antiasthmatics, cardiovasculars, antifungal, anticonvulsants, antiemetic, central nervous system, fluoroquinolones, corticosteroids, antipsychotic, antibacterial and anti-parkinson, anti-ulcerants, and prostaglandins. It also provides custom manufacturing solutions, as well as peptide synthesis services. The company was founded in 1984 and is headquartered in Hyderabad, India.
Neuland Laboratoriesと類似の将来のp / e
- Pretium Resources Incの将来のP / Eは19.28です。
- VSEの将来のP / Eは19.28です。
- Albiomaの将来のP / Eは19.31です。
- SMC (Japan)の将来のP / Eは19.31です。
- Manitowoc Coの将来のP / Eは19.32です。
- EIHの将来のP / Eは19.34です。
- Neuland Laboratoriesの将来のP / Eは19.34です。
- SKF Indiaの将来のP / Eは19.36です。
- NiSource Incの将来のP / Eは19.36です。
- WH Smith Plcの将来のP / Eは19.38です。
- Inghamsの将来のP / Eは19.38です。
- Pernod Ricard SAの将来のP / Eは19.38です。
- APRILの将来のP / Eは19.38です。